Swedish News Blog

Multiple Sclerosis Center Celebrates First Anniversary

Kate Floyd

Kate Floyd
Education Coordinator, Swedish MS Center

One year ago today, the first patients visited the brand new Multiple Sclerosis (MS) Center at Swedish Neuroscience Institute. The 11,700-square-foot facility was designed around the patient experience as part of the MS Center’s commitment to treating the whole person and addressing each patient’s individual emotional, psychological, social and physical needs in a supportive environment.

Since we opened our doors on April 9, 2012, we’ve hit a few new milestones:

  • More than 5,400 total patients, including 620 new faces, from around the world received care from our comprehensive treatment team in the last 12 months.

  • We welcomed three new providers: neurologist Peiqing Qian, M.D.; physical therapist Kim Kobata, PT; and neuro-psychiatrist Lina Fine, M.D., M.Phil.

  • We completed the Pigott Terrace. The 1,500-square-foot outdoor therapy terrace includes a one-of-a-kind system that enables patients to ...

Staying productive in the workplace with Multiple Sclerosis (MS)

Kate Floyd

Kate Floyd
Education Coordinator, Swedish MS Center

"But you're so young!" is a reaction a many people with multiple sclerosis (MS) may hear when they talk about their diagnosis. There is a common misconception that MS is diagnosed older or appear much more disabled. However, most people are diagnosed between the ages of 20 and 40, smack in the prime of her or his life and career.

MS symptoms may affect a person's ability to work and participate in an educational program more or less depending on the course of their disease. Many people wonder if they can keep working or they quit because of their MS limitations, causing financial stress.

There is a place in the workplace for people with MS and there are options to support you. Shaheen Virani is a Certified Rehabilitation Counselor at the MS Center at Swedish. A vocational counselor can help people living with MS navigate their employment options, whether it is to continue working, make a career change or apply for disability.

Vocational services at the MS Center are free and can often be coordinated with other appointments on the same day. A counselor can support people with MS in many ways, including:

MS Roadshow coming April 26 to Skagit Valley

Kate Floyd

Kate Floyd
Education Coordinator, Swedish MS Center

The MS Center at Swedish Neuroscience Institute will present the MS Roadshow April 26 in Mt. Vernon, Washington. The MS Roadshow is a free, half-day educational workshop about living well with multiple sclerosis (MS).

Knowledge really is power when it comes to managing your health. For people living with MS, learning as much as possible about the disease makes it easier to make informed decisions about your care.

Whether newly diagnosed or looking for more information to help improve your health, the MS Roadshow offers a look at leading-edge research and tips for living a full life. Topics and speakers include:

New medication for MS, Tecfidera (BG-12), Approved by FDA

James D. Bowen, MD

On March 27, the U.S. Food and Drug Administration approved the newest treatment in the increasing number of disease modifying therapies (DMTs) available to treat multiple sclerosis. Tecfidera (BG-12) is an oral capsule to treat adults with relapsing forms of MS. Research participants at the MS Center at Swedish participated in clinical trials for Tecfidera.

 

The trials reported that people taking Tecfidera had fewer relapses and less frequent worsening of disability compared to people taking a placebo. There were also fewer and less-severe side effects with Tecfidera than other treatments.

 

The studies found that ...

Stride with Swedish April 14 for Multiple Sclerosis

Kate Floyd

Kate Floyd
Education Coordinator, Swedish MS Center

Every hour, someone is diagnosed with multiple sclerosis (MS). And every day, people from around the Pacific Northwest and United States visit the MS Center at Swedish to learn how to live well with the disease.

Multiple sclerosis is a disease of the nervous system that affects the brain, eyes and spinal cord that takes a unique course in every patient. We’re with people on their journey, whether they are newly diagnosed or have been living with MS for decades. Patients and families share their lives with our treatment team and, in turn, we put our passion into helping them achieve their highest wellbeing.

Participating in Walk MS one way we show our commitment to caring for the MS community.

Swedish Presents Research at 2013 AAN Annual Meeting

Kate Floyd

Kate Floyd
Education Coordinator, Swedish MS Center

Neurologists and neuroscience professionals this week from around the world gathered at the American Academy of Neurology (AAN) 65th Annual Meeting in San Diego. The Multiple Sclerosis Center at Swedish Neuroscience Institute was pleased to co-author a few research trials presented at the meeting:

 

Teriflunomide and pregnancy

Dr. Lily Jung-Henson speaking at the AAN 65th Annual MeetingDr. Lily Jung-Henson, neurologist and Chief of Staff at Swedish Issaquah, spoke on behalf of a team of researchers about teriflunomide and a report on the safety of women who became pregnant on the medication. Teriflunomide is a once-daily, oral disease-modifying therapy (DMT) recently approved in the United States to treat relapsing multiple sclerosis. Clinical trials for teriflunomide took place among the many research studies for new treatments Swedish Neuroscience Institute offers patients with multiple sclerosis. (Read the full abstract here.)

Subset of a trial looking at endurance effects of Dalfampridine (AMPYRA®)

Dr. Angeli Mayadev, physical medicine and rehabilitation specialist at the MS Center, participated in this study of a medication to improve walking speed in people with MS. Dalfampridine -ER 10 mg twice daily significantly improved 6-minute walking distance compared to placebo. Dalfampridine 5 mg twice daily did not improve distance compared to placebo. Researchers also found that ....

MS Research Update: Pulse therapy for breakthrough multiple sclerosis

Lily K. Jung Henson, MD

A small pilot study from the University of Southern California suggests a pulse adrenocorticotropic hormone (ACTH) therapy could be effective in patients with breakthrough multiple sclerosis attacks while on beta-interferon. “Breakthrough” attacks that occur after starting a disease modifying therapy (DMT).

 

The study compared the safety and benefits of monthly pulse ACTH to monthly methylprednisone (MP) pulse in patients on beta-interferon. Over 15 months, researchers found that those treated with ACTH had fewer relapses and fewer psychiatric side effects. ACTH gel is currently used to treat MS relapses, but researchers note it may be able to alter the body’s immune responses beyond producing steroids.

 

As I discussed with the Medscape reporter, Megan Brooks, last week, the results of this study are ....

Results 85-91 of 100

More information about the Swedish newsroom

Explore the rest of the Swedish blog

Swedish has a social media policy

See who is blogging at Swedish

   Keep up with Swedish:

    Check out the Swedish blog

Find a Physician

              Subscribe to
             HealthWatch